MagnetoOrganics Overview

  • Founded
  • 2007

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

MagnetoOrganics General Information


Developer of fluid biopsy designed to treat cancer. The company's fluid biopsy characterizes circulating tumor cells (CTCs) from a cancer patient's peripheral blood to determine the tissue of origin and to monitor the evolution of the diseases, enabling doctors to diagnose disease at an earlier stage and to make treatment decisions based on the best response to therapy.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Primary Office
  • 580 Wilderness Peak Drive NorthWest
  • Issaquah, WA 98027
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MagnetoOrganics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Dec-2016 Completed Out of Business
1. Accelerator/Incubator 01-Jan-2013 Completed Generating Revenue
To view MagnetoOrganics’s complete valuation and funding history, request access »

MagnetoOrganics Executive Team (2)

Name Title Board Seat Contact Info
Paul Bentley Ph.D Chief Scientific Officer & Founder
Bob Snyder Ph.D Chief Executive Officer & President
To view MagnetoOrganics’s complete executive team members history, request access »